Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.60 |
| ▸ | F2 | P00734 | 5/20 | 0.58 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.58 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11890743 | 0.92 | F10 (0.58) | F10F2ABCB11ST14 | |
| SCHEMBL15482067 | 0.91 | F10 (0.60) | F10 | |
| SCHEMBL15475575 | 0.86 | F10 (0.69) | F10F2ABCB11ST14 | |
| SCHEMBL11890681 | 0.84 | F10 (0.58) | F10 | |
| SCHEMBL11890751 | 0.84 | F10 (0.66) | F10F2ABCB11ST14 | |
| SCHEMBL15475850 | 0.82 | F10 (0.46) | F10F2ABCB11ST14 | |
| SCHEMBL11890685 | 0.80 | F10 (0.69) | F10F2ABCB11ST14 | |
| SCHEMBL28404065 | 0.80 | F10 (0.76) | F10F2ABCB11ST14 | |
| SCHEMBL15475736 | 0.78 | F10 (0.68) | F10 | |
| SCHEMBL11890741 | 0.76 | F10 (0.65) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140050743-A1 | BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-02-20 | — | — | US | disclosed |
| US-20140050743-A1 | BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140050743-A1 | BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS | F13B, F11, SERPINC1 | F10 10/4885F2 8/4885ABCB11 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.